Clinical Trial Update: A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating Fruquintinib in combination with S-1 for advanced esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Fruquintinib (fruquintinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN